181 studies found for:    "Immune thrombocytopenia"
Show Display Options
Rank Status Study
1 Completed An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: Human immunoglobulin intravenous
2 Terminated A Study to Investigate the Efficacy and Safety of S-888711 Tablets Administered to Adult Subjects With Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia (ITP)
Interventions: Drug: placebo to S-888711;   Drug: S-888711
3 Recruiting A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: Decitabine
4 Recruiting Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy
Conditions: Immune Thrombocytopenia;   Pregnancy
Intervention: Drug: rhTPO
5 Active, not recruiting Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Intervention: Other: blood sample
6 Completed An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Intervention: Drug: Dexamethasone
7 Withdrawn The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention:
8 Recruiting Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Eltrombopag;   Drug: Romiplostin
9 Withdrawn A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Interventions: Drug: Cyclosporin A;   Drug: rhTPO
10 Completed Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)
Conditions: Chronic Thrombocytopenia;   Immune Thrombocytopenia
Interventions: Drug: Avatrombopag;   Drug: Placebo;   Drug: Standard of care
11 Unknown  Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Autoimmune Thrombocytopenic Purpura;   Autoimmune Thrombocytopenia;   Chronic Lymphocytic Leukemia;   Non Hodgkin's Lymphoma
Intervention: Drug: Eltrombopag Olamine
12 Completed Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenic Purpura;   Immune Thrombocytopenia
Interventions: Drug: romiplostim;   Drug: Placebo
13 Unknown  Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Antox tablets(Mepaco);   Other: drug therapy for ITP
14 Recruiting Study of PRTX-100 in Adult Patients With Persistent/Chronic Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: PRTX-100
15 Completed Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia
Conditions: Immune Thrombocytopenia;   Systemic Lupus Erythematosus
Intervention:
16 Recruiting Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Rituximab;   Drug: Eltrombopag;   Drug: Dexamethasone
17 Recruiting Open-Label, Dose Escalation Study of PRTX-100 in Adults With Persistent/Chronic Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: PRTX-100
18 Completed Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
Conditions: Immune Thrombocytopenia;   Chemotherapy Induced Thrombocytopenia;   Myelodysplasia;   Aplastic Anaemia
Interventions: Other: Immune Thrombocytopenics;   Other: Hypo-proliferative thrombocytopenics;   Other: Control Population
19 Withdrawn Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Interventions: Drug: Dexamethasone (4 cycles);   Drug: Dexamethasone (1 cycle)
20 Not yet recruiting Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Rituximab;   Drug: Dexamethasone;   Drug: Mycophenolate mofetil;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years